Small cell lung cancer (SCLC) is a neuroendocrine tumor of the lung that is clinically characterized by early recurrence after initial complete response to combination chemotherapy, resulting in dismal prognosis…
Introduction: Small-cell carcinoma (SCLC) accounts for 15 August 1945 of all respiratory organ cancers and has been understudied for novel therapies. Communication through embryonic cell growth factors (FGF2, FGF9…
cancer deaths in the United States in 2014. Small Cell Lung Cancer (SCLC) accounts for roughly 15% of all lung cancers. SCLC has a five-year survival rate of only ... than one-third of the rate for non-small-cell lung…
Background: The safety and efficacy of chemotherapy for relapsed small cell lung cancer (SCLC) with interstitial lung disease (ILD) is uncertain. ILD is a risk factor for acute exacerbation ... Methods: From January…
Small cell lung carcinoma (SCLC) grows extremely rapidly, becoming extensive-stage disease (ED) at the time of diagnosis. SCLC has the most aggressive clinical course of any type of pulmonary ... radiotherapy have been…
identified overexpression in many solid carcinomas. However, the expression in small cell lung cancer (SCLC) remains unclear and the association between the PD-L1 expression and prognosis is not well ... investigated…
also known as Schwartz-Bartter syndrome, is commonly caused by small cell lung carcinoma (SCLC) and is characterized by euvolemic hypoosmolar hyponatremia, which will lead to a low serum osmolality
cancer is the leading cause of death from cancer worldwide. Small cell lung cancer (SCLC) accounts for 15% to 20% of lung cancer. SCLC is characterized by a high rate ... invasion and rapid cell proliferation. The SCLC…
large cell neuro-endocrine carcinomas (LCNEC) and 60 small cell lung carcinomas (SCLC). Carcinoids were smaller in size and had higher synaptophysin and chromogranin-A, but lower TTF-1 expressions ... Patients with…
Carcinoids (AC), 32 Large Cell Neuroendocrine Carcinomas (LCNEC) and 60 Small Cell Lung Carcinomas (SCLC). Carcinoids were smaller in size and had higher synaptophysin and chromogranin A, but lower ... Patients with…
Rarely have the characteristics and prognostic factors of SCLC patients with bone metastases at first diagnosis been discussed. The purpose of this study was to examine these patients' prognostic factors ... support…
reactions from Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC) Current outcomes for Non-Small Cell Lung Cancer (NSCLC) patients treated with standard chemo- and radiotherapies ... detection. There…
world, and of all the subtypes, little cell cellular breakdown in the lungs (SCLC) represents roughly 15% of recently analyzed cellular breakdown in the lungs every year. SCLC ... conclusion. The occurrence of far off…
prediction of treatment efficacy andprognosis in patients with extensive small-cell lung cancer (SCLC). Materials and methods: Isolation and quantification of CECs from the whole-blood was performed using immune…
Spontaneous regression (SR) is extremely rare in small cell lung cancer (SCLC). The present study reports a rare case of SCLC accompanied by partial SR in a 68-year ... patient was scheduled to receive chemoradiotherapy…
showed 25 Non-Small Cell Lung Cancer (NSCLC) and 13 Small Cell Lung Cancer (SCLC). NAA/Cr, NAA/Cho and Cho/Cr ratios were calculated. Statistical analysis used: The unpaired ... ratio differences between patients and…
podocytopathy that was found to be associated with a small cell lung carcinoma (SCLC). One cycle of carboplatin-etoposide combination therapy led to resolution of nephrotic syndrome and remission ... found in control…
podocytopathy that was found to be associated with a small cell lung carcinoma (SCLC). One cycle of carboplatin-etoposide combination therapy led to resolution of nephrotic syndrome and remission ... found in control…
lung constitute approximately 15% of all lung tumors, with small cell lung cancer (SCLC) accounting for 15% of invasive cancers. Many of those tumors have radiological and clinical presentation which ... most cases…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.